Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib and Hydroxyurea in CML
NCT02480608Phase 2Completed
- Sponsor
- Leipzig University
- Start
- Apr 2004
- Primary completion
- Aug 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hydroxyurea in chronic myeloid leukemia (CML), sponsored by Leipzig University. Started Apr 2004; status: completed.
02
Drugs
hydroxyurea
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT02480608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480608.